Published online Jun 15, 2023. doi: 10.4239/wjd.v14.i6.795
Peer-review started: December 25, 2022
First decision: January 3, 2023
Revised: February 7, 2023
Accepted: May 6, 2023
Article in press: May 6, 2023
Published online: June 15, 2023
Processing time: 171 Days and 17.8 Hours
There is growing evidence that diabetes can induce cognitive decline and dementia. It is a slow, progressive cognitive decline that can occur in any age group, but is seen more frequently in older individuals. Symptoms related to cognitive decline are worsened by chronic metabolic syndrome. Animal models are frequently utilized to elucidate the mechanisms of cognitive decline in diabetes and to assess potential drugs for therapy and prevention. This review addresses the common factors and pathophysiology involved in diabetes-related cognitive decline and outlines the various animal models used to study this condition.
Core Tip: Diabetes can induce cognitive decline, a phenomenon attributed to fluctuations in glycemic status, macrovascular and microvascular disease, deterioration of insulin signaling, neuroinflammation, mitochondrial dysfunction, increases in advanced glycation end products, the effects of drugs used to treat diabetes, and diabetic autonomic dysfunction. Various animal models have been constructed to examine the pathophysiology of diabetes-induced cognitive decline.
